Average Semaglutide Weight Loss Results

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as one of the most studied medications for weight management, with landmark trials demonstrating consistent results across diverse patient populations. Most people taking semaglutide experience measurable weight loss within the first month, with the most significant changes occurring between weeks 8 and 20 of treatment. Understanding what realistic outcomes look like can help you make an informed decision about whether this approach aligns with your health goals.

Semaglutide Weight Loss: What Clinical Trials Actually Show

The STEP trials, the largest and most rigorous semaglutide studies to date, tracked over 4,500 adults with obesity or overweight with weight-related conditions. Participants receiving the highest dose of semaglutide (2.4 mg weekly) lost an average of 15.3% of their starting body weight—roughly 21 pounds for someone weighing 137 pounds at baseline. By comparison, people taking a placebo lost only 2.6% of their body weight on average. These results held steady even after one year of continued treatment, showing that weight loss was not temporary.

Individual outcomes vary considerably based on factors like starting weight, metabolism, diet, exercise habits, and how your body responds to GLP-1 receptor activation. Some patients experience weight loss of 20-25% of their body weight, while others see more modest results in the 5-10% range. Response variation is one reason PlexusDx offers the Precision Peptide Genetic Test—this peptide-pathway analysis examines key genetic variants including GLP1R rs6923761 and MC4R rs17782313 to help predict your medication response and optimize your treatment plan from the start.

How Semaglutide Produces Weight Loss and When Results Appear

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that signals fullness, reduces hunger, and slows stomach emptying. These combined effects create a genuine decrease in appetite and calorie intake—not willpower alone, but a physiological shift in how your brain and gut communicate. Most patients notice reduced hunger and increased food satisfaction within days to weeks of starting treatment, which makes it easier to maintain a calorie deficit without constant food cravings.

Weight loss typically accelerates during weeks 4-8 as your body adjusts to the medication and as dose increases take effect. The most dramatic changes generally occur between weeks 8 and 20, when many patients report losing 1-2 pounds per week. After 20 weeks, the rate of weight loss often stabilizes but continues, with total reductions becoming visible around the 3-month mark and becoming substantial by 6 months. Plateau periods are normal and temporary; many people resume weight loss after adjusting to a higher dose or making small lifestyle shifts.

Factors That Influence Your Individual Semaglutide Results

Genetics play a significant role in how your body responds to semaglutide. Variations in the GLP1R gene, the FTO gene (which affects hunger regulation), and the GIPR gene influence both your baseline appetite and how effectively semaglutide suppresses it. People with certain genetic patterns may experience faster or more pronounced weight loss, while others may need a higher dose to achieve the same effect. This genetic diversity is why one-size-fits-all dosing often falls short—PlexusDx's Precision Peptide Genetic Test maps 14 pathways and 150+ genetic insights to reveal your peptide-pathway profile and guide dose selection.

Lifestyle factors remain critical even with medication support. Patients who combine semaglutide with structured eating patterns, adequate protein intake, and regular physical activity typically lose more weight than those relying on medication alone. Sleep quality, stress management, and hydration also affect weight loss speed and sustainability. Additionally, any existing medications, metabolic conditions like thyroid disease, and past weight loss attempts all shape your trajectory. PlexusDx providers review these factors during your initial assessment to set realistic expectations and create a personalized protocol.

Comparing Semaglutide to Other GLP-1 Options and Maintaining Results

Semaglutide is available in two formulations: injectable and oral. Compounded semaglutide injections from licensed 503A pharmacies typically produce faster and more reliable weight loss compared to oral versions because they bypass the digestive system and achieve higher, more stable blood levels. PlexusDx offers compounded semaglutide injections starting at $149 per month, with your dose increasing as needed while your price remains flat. Some patients explore dual-compound options like GLP-Squared Injection, which combines semaglutide with tirzepatide for enhanced results in cases where a single agent plateaus.

Weight maintenance after reaching your goal typically requires continuing treatment, though many patients eventually stabilize at lower doses. Clinical data shows that stopping semaglutide leads to gradual weight regain over 1-2 years as hunger hormones normalize and appetite returns. Long-term weight loss success depends on building sustainable habits—improved food choices, consistent movement, and emotional eating awareness—that persist even if medication is eventually tapered. PlexusDx supports this transition with ongoing provider guidance and genetic insights that explain your unique metabolic tendencies, making behavioral change feel more achievable and permanent.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose if I take semaglutide?

Average weight loss ranges from 10-15% of body weight over 68 weeks based on clinical trials, though individual results vary widely. Some people lose 20-25% of their starting weight, while others see 5-10% loss depending on genetics, lifestyle, and baseline metabolism. PlexusDx's Precision Peptide Genetic Test can help identify your likely respo...

How quickly do you lose weight on semaglutide?

Most patients notice reduced appetite within days to weeks. Visible weight loss typically appears around week 4, with the fastest losses occurring between weeks 8-20. After 3 months, most people see 5-10 pounds of loss; after 6 months, results are often substantially more dramatic. Weight loss pace depends on your genetics, starting weight, and ...

Does PlexusDx semaglutide cost change if my dose increases?

No—PlexusDx's pricing model keeps your monthly cost flat as your dose increases. Compounded semaglutide injections start at $149 per month regardless of dose level. This means your cost stays the same whether you're at 0.25 mg or 2.4 mg weekly, with no surprise price jumps.

Is compounded semaglutide from PlexusDx as effective as brand-name versions?

PlexusDx semaglutide is produced by licensed 503A compounding pharmacies using the same active pharmaceutical ingredient (semaglutide) as brand medications. Clinical outcomes are comparable; the main difference is cost and accessibility. PlexusDx serves all 50 states without requiring insurance, with HSA/FSA eligibility and flat pricing across a...

Can genetic testing predict my weight loss with semaglutide?

The PlexusDx Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes that influence hunger, satiety, and how your body responds to GLP-1 medications. These insights don't guarantee outcomes but help explain your metabolic tendencies and can guide dose selection and lifestyle recommendations for faster, more sustainab...

What Is the Average Weight Loss with Semaglutide?